JEFFREY MOULTON: Open Payments
NPI 1518009612 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 87 payments from 17 companies in 2025. Trend: 2023 $1,753 · 2024 $1,941 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $245 |
| ABBVIE INC. | 13 | $227 |
| Regeneron Healthcare Solutions, Inc. | 9 | $223 |
| Novartis Pharmaceuticals Corporation | 8 | $217 |
| UCB, Inc. | 20 | $173 |
| PFIZER INC. | 8 | $162 |
| Arcutis Biotherapeutics, Inc. | 3 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Organon LLC | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
Products named: DUPIXENT, Bimzelx, CIBINQO, SKYRIZI, Zoryve, COSENTYX, RINVOQ, Sotyktu.
Industry payments across FL — which companies pay providers there.
